ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $123,288,000 | +57.3% | 6,537,011 | -1.9% | 0.01% | +66.7% |
| Q2 2019 | $78,402,000 | -12.3% | 6,661,135 | +1.7% | 0.00% | -25.0% |
| Q1 2019 | $89,397,000 | +65.6% | 6,549,249 | +24.4% | 0.00% | +100.0% |
| Q4 2018 | $53,969,000 | -37.1% | 5,265,230 | +2.2% | 0.00% | -33.3% |
| Q3 2018 | $85,817,000 | +7.8% | 5,154,209 | +2.3% | 0.00% | 0.0% |
| Q2 2018 | $79,613,000 | +18.7% | 5,038,834 | -4.6% | 0.00% | 0.0% |
| Q1 2018 | $67,046,000 | +9.3% | 5,279,275 | -1.5% | 0.00% | 0.0% |
| Q4 2017 | $61,364,000 | -0.3% | 5,359,236 | +6.6% | 0.00% | 0.0% |
| Q3 2017 | $61,564,000 | +48.3% | 5,025,577 | +38.6% | 0.00% | +50.0% |
| Q2 2017 | $41,525,000 | -41.9% | 3,626,573 | +5.5% | 0.00% | -50.0% |
| Q1 2017 | $71,524,000 | +6.0% | 3,438,702 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $67,486,000 | -34.7% | 3,244,517 | +2.9% | 0.00% | -33.3% |
| Q3 2016 | $103,329,000 | +33.8% | 3,153,148 | +2.0% | 0.01% | +20.0% |
| Q2 2016 | $77,220,000 | +43.4% | 3,092,518 | +40.6% | 0.01% | +66.7% |
| Q1 2016 | $53,857,000 | -24.2% | 2,199,184 | +2.3% | 0.00% | -40.0% |
| Q4 2015 | $71,006,000 | -82.2% | 2,149,724 | -79.9% | 0.01% | -66.7% |
| Q3 2015 | $398,906,000 | +513.5% | 10,673,516 | +769.5% | 0.02% | +275.0% |
| Q2 2015 | $65,020,000 | +280.2% | 1,227,483 | +107.1% | 0.00% | +300.0% |
| Q1 2015 | $17,103,000 | +151.6% | 592,609 | +153.5% | 0.00% | – |
| Q4 2014 | $6,799,000 | +268.5% | 233,730 | +60.6% | 0.00% | – |
| Q3 2014 | $1,845,000 | +11.9% | 145,523 | +77.2% | 0.00% | – |
| Q2 2014 | $1,649,000 | – | 82,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |